ALX ONCOLOGY HLDGS INC
ALXO·00166B105·US·Common Stock·Healthcare - Biotechnology-Activist
ALXO (ALX ONCOLOGY HLDGS INC) is held by 45 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($26.1M), Blackstone Inc. ($11.7M), DRIEHAUS CAPITAL MANAGEMENT LLC ($11.5M). Net institutional sentiment: Bullish.
45
Holders
Avg rating(6 Elite)
$90.7M
Total Value
73% (51)
Fund Consensus
29 buying - 11 selling
Who's Trading
ActivistLALSV Associates, LLC1.2%May 27, 2026
ActivistHHHBM Healthcare Investments (Cayman) Ltd.6.5%May 15, 2026
ActivistRERedmile Group, LLC6.8%May 15, 2026
InsiderLJLettmann JasonSell $27KMar 19, 2026
InsiderPSPinto ShellySell $2KMar 19, 2026
InsiderPSPinto ShellySell $1KFeb 18, 2026
ActivistTCTCG Crossover GP II, LLC5.0%Feb 6, 2026
InsiderPSPinto ShellySell $4KJan 6, 2026
13F: Insider & Congress:
Showing 1-20 of 51
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer